Thank you. It would seem that with the company's focus on biomarkers & the new lab that all perceived problems can be addressed at some point.
Maybe a better situation than cleaning up behind someone else. I would not think it would take that much longer (possibly better received).
As NP suggested, inventory may be depleted long before HIV approval. If this were to be the case, then pooling resources now seems more viable.
So glad that they intend to hire more people to ensure that CYDY can manage regulatory process.
This does not look like a company that is seeking BP partners or intends to sell. I like it.